All In MedTech

FDA Clearance Tracker · P060010-S013

The Spanner Temporary Prostatic Stent

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Oct 7, 2022 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Oct 7, 2022

Approved

Time to decision

837 days

Received Jun 22, 2020. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Panel Track

Device class

Class III

The decision

FDA number
P060010-S013
Device name
The Spanner Temporary Prostatic Stent
Applicant
Srs Medical
Applicant location
North Billerica, MA
Received
Jun 22, 2020
Decided
Oct 7, 2022
Decision
Approved
Supplement type
Panel Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P060010

Device type

Device class
Class III

Every decision under product code NZC

FDA's approval statement

As written in FDA's record.

Approval for the Spanner Prostatic Stent. The device is intended for temporary use (up to 30 days) to maintain urine flow and allow voluntary urination for patients who are not candidates for pharmacologic, minimally invasive or surgical treatment of the prostate.

Source documents

Other decisions for Srs Medical

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.